SNOWDEN KABUSHIKI KAISHA – Trademark Portfolio
Entity Type: 03
SNOWDEN KABUSHIKI KAISHA holds 13 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 8 filings in this category. The portfolio also extends into Class 3 (Cosmetics & Cleaning) across 3 Nice Classification classes. Currently, 4 trademarks are registered and 1 is pending. Notable registered marks include FIVELAC, SNOWPIA, THREELAC, and ASHIYAROYAL. The owner is based in Tokyo.
7-16 Iwamoto-cho 3-chome, Chiyoda-ku
Tokyo , JP
Showing of trademarks Trademarks
Trademark Classifications
SNOWDEN KABUSHIKI KAISHA's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring
Frequently Asked Questions
How many trademarks does SNOWDEN KABUSHIKI KAISHA have?
SNOWDEN KABUSHIKI KAISHA has 13 U.S. trademarks filed with the USPTO. Of these, 4 registered, 1 pending, 5 abandoned, 2 cancelled.
What trademark classes does SNOWDEN KABUSHIKI KAISHA file in?
SNOWDEN KABUSHIKI KAISHA files trademarks across 3 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 3 (Cosmetics & Cleaning), Class 1 (Chemicals). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are SNOWDEN KABUSHIKI KAISHA's most well-known trademarks?
SNOWDEN KABUSHIKI KAISHA's registered trademark portfolio includes well-known marks such as FIVELAC, SNOWPIA, THREELAC, and ASHIYAROYAL. These are among 4 currently registered trademarks in the portfolio.
What is SNOWDEN KABUSHIKI KAISHA's trademark registration success rate?
SNOWDEN KABUSHIKI KAISHA has a 36% trademark registration rate, with 4 out of 11 resolved applications resulting in successful registration. Currently, 1 application is pending review.